FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) today announced highlights from its analyst and investor meeting which was held on Thursday, February 17 in San Diego, CA in conjunction with the American Academy of Orthopedic Surgery (AAOS) Annual Meeting. The BioMimetic management team provided updates regarding the Company’s May 12, 2011 Orthopedic and Rehabilitation Devices Panel Meeting to review the Premarket Approval (PMA) application for Augment™ Bone Graft for the treatment of foot and ankle fusions in the U.S. The Company also released results of its pre-clinical study of interbody lumbar spine fusion and provided updates on other product development activities.
